Skip to main content
. 2016 Feb 23;24(2):332–342. doi: 10.1016/j.jfda.2015.11.010

Figure 5.

Figure 5

(A) Time- and dose-dependent effects of the WG-9 peptide on viability of HFLF-PI-5 cells evaluated by MTT assay. The peptide had no significant effect on the treated cells after 24 hours (p < 0.05). (B) Hemolytic activity of the WG-9 peptide against human erythrocytes. The assay was carried out in triplicate. MTT = 3-(4,5-dimethylthia-zol-2-yl)-2,5-diphenyltetrazolium bromide.